Adam Gedney, PA
Physician Assistant · Conway, SCNPI 1326109018
Payments from drug & device makers
Across 131 payments — averaging $19.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$337
- Phathom Pharmaceuticals, Inc.$271
- Amgen$258
- Novo Nordisk$226
- GSK$198
- AbbVie$174
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,618100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $337 |
| Phathom Pharmaceuticals, Inc. | 8 | $271 |
| Amgen | 11 | $258 |
| Novo Nordisk | 12 | $226 |
| GSK | 12 | $198 |
| AbbVie | 10 | $174 |
| Dexcom, Inc. | 3 | $146 |
| Abbott | 5 | $112 |
| Merck | 5 | $90 |
| Sumitomo Pharma America, Inc. | 3 | $75 |
| Lilly USA, LLC | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Forte Bio-pharma LLC | 5 | $66 |
| Astellas Pharma US Inc | 4 | $65 |
| Radius Health, Inc. | 3 | $54 |
| Exact Sciences | 3 | $52 |
| Sunovion Pharmaceuticals Inc. | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| E.r. Squibb & Sons, L.L.C. | 3 | $42 |
| Nevro Corp. | 2 | $42 |
| Corium, LLC | 1 | $33 |
| Boehringer Ingelheim | 2 | $33 |
| Ardelyx, Inc. | 2 | $32 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Irhythm Technologies, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Novartis | 1 | $13 |
| Bayer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOQUEZNA$232
- DEXCOM G7 GSS (161)$116
- Repatha$115
How this compares
$2,618 in reported general payments places this provider in the 80th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 84 | $127,032 |
| EliquisApixaban | 125 | $110,754 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 80 | $86,159 |
| JardianceEmpagliflozin | 72 | $80,785 |
| FarxigaDapagliflozin Propanediol | 73 | $72,992 |
| LinzessLinaclotide | 44 | $38,220 |
| RybelsusSemaglutide | 23 | $35,684 |
| Repatha SureclickEvolocumab | 31 | $33,416 |
| MounjaroTirzepatide | 30 | $31,756 |
| MyrbetriqMirabegron | 36 | $28,410 |
| JanuviaSitagliptin Phosphate | 30 | $25,987 |
| VraylarCariprazine Hcl | 16 | $25,274 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 11 | $18,502 |
| TrulicityDulaglutide | 16 | $18,262 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $18,223 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $226 | $175,814154 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $198 | $106,891119 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $337 | $95,322113 claims |
| Boehringer IngelheimJardiance, Jentadueto Xr | $33 | $86,59883 claims |
| AbbVieLinzess, Vraylar | $174 | $63,49460 claims |
| Lilly USA, LLCMounjaro, Trulicity | $72 | $50,01746 claims |
| MerckJanuvia, Dulera | $90 | $36,29050 claims |
| Astellas Pharma US IncMyrbetriq | $65 | $28,41036 claims |
| Johnson & JohnsonXarelto | $14 | $18,05318 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $75 | $13,58717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Conway
- Nicholas SottileConway$14K
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Vicki RobertsWest Columbia$77K
- Eric ShoupColumbia$74K
- Lauren OlsonNorth Charleston$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.